Specific for PiTX3
PiTX3 is a member of the homeodomain family of DNA binding proteins known as the RIEG/PITX homeobox gene family, which includes PiTX1, PiTX2, and PiTX3. PiTX3 is associated with early ocular development and is later expressed in other organs and limbs. PiTx3 is expressed in the eyes (specifically the developing lens) and has a highly restricted expression pattern in the brain. Mutations of the PiTX3 gene have been associated with anterior segment dysgenesis and a familial form of congenital cataracts.
ABfinity™ antibody characteristics include:
- Validation in Western blot and indirect ELISA
- Superior lot-to-lot consistency
- Extremely high specificity and sensitivity
- Recombinant rabbit monoclonal antibody
ABfinity™ antibodies are produced by transfection of mammaliancells with heavy and light chain antibody cDNAs. This provides you withthe highest consistency between lots, eliminating the need torevalidate your assays for each lot.
High Specificity Means More Reliable Data
The proprietary recombinant technology employed in the production ofABfinity™ antibodies means you are assured of the greatest degreeof reliability. Staining of nonspecific proteins is virtuallyeliminated while very high sensitivity is achieved. Life Technologies scientists havevalidated this antibody for Western blotting.
High Sensitivity Lets You Detect Low Levels of Target Protein
ABfinity™ antibodies demonstrate much higher sensitivity thanordinary antibodies. Proteins expressed in low levels can be detectedwith high specificity allowing you to use less of your precious samplesthan with ordinary antibodies.
Recombinant Rabbit IgG—Use Like Any Other IgG Antibody
As with traditional IgG antibodies, gel electrophoresis ofABfinity™ antibodies produces a 150 kDa band under non-reducingconditions and 50 kDa and 25 kDa bands under reducing conditions.
For Research Use Only. Not intended for any animal or human therapeuticor diagnostic use.
Learn moreabout the superior performance of ABfinity™ recombinantmonoclonal antibodies
SeeLife Technologies's full line of ABfinity™ recombinant monoclonalantibodies